A detailed history of Hrt Financial LP transactions in Vericel Corp stock. As of the latest transaction made, Hrt Financial LP holds 21,127 shares of VCEL stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,127
Holding current value
$1.23 Million
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$42.25 - $53.56 $892,615 - $1.13 Million
21,127 New
21,127 $892,000
Q4 2023

Feb 09, 2024

SELL
$30.85 - $37.09 $557,613 - $670,401
-18,075 Reduced 63.81%
10,253 $365,000
Q3 2023

Nov 13, 2023

SELL
$31.69 - $39.25 $840,387 - $1.04 Million
-26,519 Reduced 48.35%
28,328 $949,000
Q2 2023

Aug 11, 2023

SELL
$29.0 - $38.37 $226,954 - $300,283
-7,826 Reduced 12.49%
54,847 $2.06 Million
Q1 2023

May 12, 2023

BUY
$23.85 - $31.34 $1.49 Million - $1.96 Million
62,673 New
62,673 $1.84 Million
Q3 2022

Nov 14, 2022

BUY
$22.62 - $32.54 $177,951 - $255,992
7,867 Added 25.35%
38,897 $902,000
Q2 2022

Aug 12, 2022

BUY
$22.88 - $39.45 $267,055 - $460,460
11,672 Added 60.3%
31,030 $781,000
Q1 2022

May 16, 2022

BUY
$31.69 - $43.29 $613,455 - $838,007
19,358 New
19,358 $739,000
Q3 2021

Nov 15, 2021

SELL
$46.35 - $59.75 $1.75 Million - $2.26 Million
-37,787 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$47.2 - $67.81 $1.78 Million - $2.56 Million
37,787 New
37,787 $1.98 Million
Q4 2020

Feb 16, 2021

SELL
$18.53 - $31.5 $858,235 - $1.46 Million
-46,316 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$14.68 - $19.12 $679,918 - $885,561
46,316 New
46,316 $858,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.74B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.